These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7959868)

  • 21. Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection.
    Wozniak TM; Ryan AA; Triccas JA; Britton WJ
    Infect Immun; 2006 Jan; 74(1):557-65. PubMed ID: 16369012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the protective efficacy of bacille calmette-Guérin vaccination against aerosol challenge with Mycobacterium tuberculosis and Mycobacterium bovis.
    Williams A; Davies A; Marsh PD; Chambers MA; Hewinson RG
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S299-301. PubMed ID: 10875804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacille Calmette-Guérin vaccination enhances human gamma delta T cell responsiveness to mycobacteria suggestive of a memory-like phenotype.
    Hoft DF; Brown RM; Roodman ST
    J Immunol; 1998 Jul; 161(2):1045-54. PubMed ID: 9670986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complement C5a anaphylatoxin is an innate determinant of dendritic cell-induced Th1 immunity to Mycobacterium bovis BCG infection in mice.
    Moulton RA; Mashruwala MA; Smith AK; Lindsey DR; Wetsel RA; Haviland DL; Hunter RL; Jagannath C
    J Leukoc Biol; 2007 Oct; 82(4):956-67. PubMed ID: 17675563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
    Changhong S; Hai Z; Limei W; Jiaze A; Li X; Tingfen Z; Zhikai X; Yong Z
    Tuberculosis (Edinb); 2009 Jan; 89(1):54-61. PubMed ID: 19056317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neutrophils from Mycobacterium avium-infected mice produce TNF-alpha, IL-12, and IL-1 beta and have a putative role in early host response.
    Petrofsky M; Bermudez LE
    Clin Immunol; 1999 Jun; 91(3):354-8. PubMed ID: 10370382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contribution of CD30/CD153 but not of CD27/CD70, CD134/OX40L, or CD137/4-1BBL to the optimal induction of protective immunity to Mycobacterium avium.
    Flórido M; Borges M; Yagita H; Appelberg R
    J Leukoc Biol; 2004 Nov; 76(5):1039-46. PubMed ID: 15316035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycobacterium avium subsp. paratuberculosis-specific mpt operon expressed in M. bovis BCG as vaccine candidate.
    Heinzmann J; Wilkens M; Dohmann K; Gerlach GF
    Vet Microbiol; 2008 Aug; 130(3-4):330-7. PubMed ID: 18343053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunization with a DNA vaccine cocktail induces a Th1 response and protects mice against Mycobacterium avium subsp. paratuberculosis challenge.
    Park SU; Kathaperumal K; McDonough S; Akey B; Huntley J; Bannantine JP; Chang YF
    Vaccine; 2008 Aug; 26(34):4329-37. PubMed ID: 18582521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of different formulations of oral Mycobacterium bovis Bacille Calmette-Guérin (BCG) vaccine in rodent models for immunogenicity and protection against aerosol challenge with M. bovis.
    Clark S; Cross ML; Smith A; Court P; Vipond J; Nadian A; Hewinson RG; Batchelor HK; Perrie Y; Williams A; Aldwell FE; Chambers MA
    Vaccine; 2008 Oct; 26(46):5791-7. PubMed ID: 18789366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relative impact of bacterial virulence and host genetic background on cytokine expression during Mycobacterium avium infection of mice.
    Castro AG; Minóprio P; Appelberg R
    Immunology; 1995 Aug; 85(4):556-61. PubMed ID: 7558149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aerosol infection of mice with recombinant BCG secreting murine IFN-gamma partially reconstitutes local protective immunity.
    Moreira AL; Tsenova L; Murray PJ; Freeman S; Bergtold A; Chiriboga L; Kaplan G
    Microb Pathog; 2000 Sep; 29(3):175-85. PubMed ID: 10968949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Correlation between the expression of perforin in T-lymphocyte subsets and antituberculosis in mice vaccinated with bacillus calmette-guerin].
    Lei JP; Wan Y; Zhou J; Wu Q
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Oct; 33(10):771-4. PubMed ID: 21176510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [BCG-induced T cell anergy and its activation by IL-4].
    Nishioka Y; Nakanishi K; Sugita M
    Arerugi; 1998 May; 47(5):533-42. PubMed ID: 9656576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of atypical mycobacterial infection on the cell-mediated immunity induced by Mycobacterium bovis BCG in mice. II. Suppression of protective immunity].
    Nakamura RM
    Kekkaku; 1993 May; 68(5):361-5. PubMed ID: 8331880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adoptive immunity to Mycobacterium bovis strain bacillus Calmette-Guérin by long-term cultured T-cell line in nude mice.
    Yamamoto S; Iwai H; Ueda K
    Immunology; 1989 Oct; 68(2):253-9. PubMed ID: 2680910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunization of mice with Mycobacterium leprae/Mycobacterium bovis BCG admixtures: modulation of the acquired response to BCG.
    Orme IM
    Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):293-8. PubMed ID: 3298475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PD-L2 induction on dendritic cells exposed to Mycobacterium avium downregulates BCG-specific T cell response.
    Mendoza-Coronel E; Camacho-Sandoval R; Bonifaz LC; López-Vidal Y
    Tuberculosis (Edinb); 2011 Jan; 91(1):36-46. PubMed ID: 21147037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resistance of various strains of mycobacteria to killing by activated macrophages in vivo.
    Orme IM; Collins FM
    J Immunol; 1983 Sep; 131(3):1452-4. PubMed ID: 6411817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross-reactive immune responses against Mycobacterium bovis BCG in mice infected with non-tuberculous mycobacteria belonging to the MAIS-Group.
    Lozes E; Denis O; Drowart A; Jurion F; Palfliet K; Vanonckelen A; De Bruyn J; De Cock M; Van Vooren JP; Huygen K
    Scand J Immunol; 1997 Jul; 46(1):16-26. PubMed ID: 9246204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.